The goal of this study was to develop a suitable kinetic analysis method for quantification of 5-HT 2A receptor parameters with e 'ClMDL 100,907, Twelve control studies and four preblocking studies (400 nmol/kg unlabeled MDL 100,907) were performed in isoflurane-anesthetized rhesus monkeys, The plasma input function was determined from ar terial blood samples with metabolite measurements by extrac tion in ethyl acetate, The preblocking studies showed that a two-tissue compartment model was necessary to fit the time activity curves of all brain regions including the cerebellum in other words, the need for two compartments is not proof of specific binding, Therefore, a three-tissue compartment model was used to analyze the control studies, with three parameters
Positron emission tomography (PET) has been used to measure receptor-related parameters in vivo for several neurotransmitter systems. The 5-HT2A receptor may play an important role in several psychiatric disorders such as depression (Yates et aI., 1990) and schizophrenia (Joyce et aI., 1993) , so a reliable tracer method for evaluation of these receptors would be of great use. Various radiophar maceuticals have been developed to investigate 5-HT2A receptors, including [llC]N-methylspiperone (Wong et aI., 1984) , [18F]setoperone (Blin et aI., 1988) , and [,8F]altanserin (Sadzot et aI., 1995) . These tracers, how ever, either do not show high selectivity for the 5-HT2A SUbtype or have radioactive metabolites that cross the blood-brain barrier.
MDL 100,907 ((R)-( + )-a-(2,3-dimethoxyphenyl)-1- [2-( 4-fluorophenyl) ethyl]-4-piperidine methanol) is a highly selective 5-HT 2A receptor antagonist (Sorensen et aI., 1993) . Several investigators have evaluated [' IC]MDL fixed based on the preblocking data, Reliable fits of control data could be obtained only if no more than three parameters were allowed to vary, For routine use of ["ClMDL 100,907, several simplified methods were evaluated. A two-tissue (2T') compartment with one fixed parameter was the most reliable compartmental approach; a one-compartment model failed to fit the data adequately, The Logan graphical approach was also tested and produced comparable results to the 2T' modeL How ever, a simulation study showed that Logan analysis produced a larger bias at higher noise levels, Thus, the 2T' model is the best choice for analysis of ["ClMDL 100,907 studies, Key Words: 5-HT2A receptors-Modeling-Positron emission to mography-Serotonin. 100,907 with PET. Mathis et al. (1996) demonstrated in vivo specific binding in rat and baboon. Lundkvist et aI. (1996) also performed displacement and pretreatment studies with ketanserin and showed no evidence of spe cific binding in the cerebellum. Ito et al. (1998) pre sented the first data obtained in humans with ["C]MDL 100,907. They applied a model with two tissue (2T) compartments for analyzing regional time-activity curves (TACs), and all regions including the cerebellum were well described by this model. Because the cerebel lum curve was not adequately described by a one-tissue (1 T) compartment model, they concluded that specific binding in the cerebellum could not be neglected and that a reference region approach was not fully appropriate.
To evaluate this tracer further, we performed studies in rhesus monkeys with [IIC]MDL 100,907. We used pre blocking studies to determine the appropriate model con figuration for free and nonspecifically bound tracer. From this model, we added a compartment for specific binding to be used for analysis of control data. By com paring control and preblocking studies, we determined whether there is specific binding in the cerebellum. We also tested several simpler methods to analyze ["C]MDL 100,907 data with the goal of defining a suit able method to quantify 5-HT2A receptor parameters when preblocking data are unavailable.
METHODS

Radiosynthesis
e lC]Methyl iodide was trapped at room temperature in a vial containing the 3-hydroxy precursor (MDL 105725, 0.200 mg; 0.56 J.1moles) , acetone (400 J.1L) and tetrabutylammonium t1uoride (2 J.1L, 1.0 mollL in tetrahydrofuran) less than 20 min utes before alkylation. The vessel was sealed and heated to 80°C for 3 minutes. The mixture was filtered (10 J.1m polyeth ylene frit), diluted with 500 J.1L high pressure liquid chroma tography (HPLC) eluent, and transferred into an HPLC injec tor. The mixture was purified by semi preparative HPLC (52% 10 mmollL TEA-NaH2P04 [pH 8], 4S% acetonitrile) at 6 mLi min on a Beckman Ultrasphere ODS (Thomson, Springfield, MA, U.S.A.), 5 J.1, 10 x 250-mm column. The product, [11C]MDL 100907, was eluted at the same retention time as authentic standard (9.25 minutes). The eluent was diluted with 20 mL water and passed through a l-mL C-18 cartridge (Wa ters Lite, Milford, MA, U.S.A.) and washed with 5 mL water. The trapped activity was eluted with 0.5 mL ethanol and diluted to 10 mL with normal saline. The specific activity and radio chemical yield at end of bombardment were 6,600 ± 2,300 mCilJ.1mol and 17% ± 8%, respectively. Radiochemical purity was 99.0% ± 0.9%.
PET studies
PET studies were performed in rhesus monkeys (6.3 to 12.6 kg). The animals were initially anesthetized with ketamine to permit endotracheal intubation and insertion of an intravenous line. The monkeys were then transported to the PET suite and placed under isot1urane anesthesia (I % to 2%). Head position was fixed with a stereotactic head holder to obtain coronal brain slices. Blood pressure, electrocardiogram, temperature, and end-tidal Peo2 were continuously monitored. These studies were carried out under a protocol approved by the NIH Clinical Center Animal Care and Use Committee.
In three monkeys, two control scans were performed in the same day for test-retest comparisons, with injections separated by approximately 3 hours. In four monkeys, a control study was performed, followed by a preblocking study. In two additional monkeys, a single control study was performed. Thus, a total of 12 control and 4 preblocking studies were performed.
PET scans were acquired on the GE Advance tomograph (GE Medical Systems, Waukesha, WI, U.S.A.), which acquires 35 slices, 4.25 mm apart, with 6-to 7-mm reconstructed trans verse resolution. After a transmission scan, three scans with 4-mCi injections of eSO]water were performed to measure cerebral blood flow (CBF) using three-dimensional acquisition and reconstruction, including the scatter correction of Stearns (1995) . Arterial blood was continuously withdrawn (3.S mLi min) during a I-minute scan, radioactivity was counted with a NaI(TI) detector, and data were corrected for randoms, dead time, and sensitivity. Dispersion correction was performed by deconvolution of the measured dispersion function, and time shifts between blood and brain data were determined by align ing scanner count rate data to the blood data. The resulting arterial input function was used to calculate CBF (Herscovitch et aI., 1983) , assuming a partition coefficient of O.S mLig. Three studies were acquired and averaged to reduce the statis tical uncertainty in the CBF values.
[11C]MDL 100,907 was administered as a bolus. Because accurate measurement of the input function is critical for ki netic modeling, the injected radioactivity dose of 20 to 39 mCi was selected to achieve a high radioactivity concentration in the blood to improve our ability to detect plasma metabolites by HPLC, where the sample fractions at late times are count-
limited. The specific activity at injection time was 700 to I,SOO mCilJ.1mol, and the injected mass of MDL 100,907 was 3.0 ± 1.4 nmol/kg. Dynamic scans were acquired in two-dimensional mode (three-dimensional mode was not used because the ran doms and deadtime would be too high) for 120 minutes, con sisting of 33 frames with durations ranging from 30 seconds to 5 minutes. Scatter correction was performed with the method of Bergstrom et al. (1983) .
To estimate the level of nonspecific binding, we performed preblocking studies in which 400 nmollkg unlabeled MDL 100,907 was administered as an intravenous bolus 5 minutes before the tracer injection. To assess whether receptor occu pancy by the injected MDL 100,907 in the control studies was detectable, in one monkey we performed two PET scans with a large difference in injected mass at the same radioactivity dose. In the first scan, approximately 3 mCi e lC]MDL 100,907 (0.225 nmollkg) was administered and a 120-minute dynamic scan was performed in three-dimensional mode. For the second scan, approximately 3 hours later, unlabeled MDL 100,907 was added to approximately 3 mCi of e lC]MDL 100,907 to pro duce a total mass dose of approximately 3 nmollkg, comparable to that of the 12 control scans.
Input function
Arterial blood samples were taken from a permanently im planted arterial access port. Each sample was centrifuged for I minute, and a O.I-mL aliquot of plasma was counted in a cali brated gamma counter. Ten samples (3, 5, 8, 12, 20, 30, 40, 50, 60 , and 90 minutes) were used for metabolite determination by ethyl acetate extraction. In addition, as a reference sample, we collected one blood sample before tracer injection to which e lC]MDL 100,907 was added. For each sample, a 0.15-mL aliquot of plasma was added to 0.45 mL borate buffer (pH 9), followed by 0.6 mL ethyl acetate. The mixture was centrifuged, and samples of the organic and aqueous phases were counted. To determine whether the radioactivity in the organic phase was only parent compound, HPLC analysis of the ethyl acetate phase of samples taken at 0, 5, 12, 20, and 30 minutes was performed (later samples were not analyzed by HPLC because of insufficient counting statistics). A Waters Symmetry C-IS column (3.9 x 150 mm) (Waters) was used with solvent 37% acetonitrile and 63% 10 mmollL TEA-NaH2P04 buffer. HPLC fractions were collected for 30 minutes (1 sample per minute), and each sample was counted in the calibrated gamma counter. The averagc recovery of counts from the HPLC samples was 92.6% ± 4.1 %. HPLC results showed that only the parent com pound was extracted by ethyl acetate; in other words, there are no lipophilic metabolites of e lC]MDL 100,907. Therefore, the fraction of counts in the ethyl acetate phase can be used to determine the parent fraction. The reference sample was also used to measure the fraction of radioactivity unbound to plasma proteins (free fr action) by ultrafiltration.
The un metabolized fr action, M(t), of the arterial input func tion was determined from the ratio of organic phase to total plasma counts, after correction for the extraction efficiency based on the reference sample (mean extraction efficiency S6.5% ± 1.3%). The following empirical equation was used to describe M(t):
(1) where the parameters a and 13 were estimated by nonlinear least-squares fitting. This empirical equation was designed to equal I at time 0 with a zero first derivative.
Data analysis
Irregular regions of interest (ROIs) were drawn on images summed from portions of the dynamic scans (0 to 5 and 40 to 60 minutes). The regions were frontal, cingulate, occipital, pa rietal, and temporal cortex, basal ganglia, thalamus, and cer ebellum. In addition, a region that encompassed the whole brain was defined on 14 or IS slices by automatic edge detec tion. TACs were generated for each region.
Preblocking study analysis. First, the data from the preblock ing studies were analyzed to determine the appropriate model for free and nonspecific binding, under the assumption that all the specific 5-HT 2A binding sites were occupied by the injec tion of cold MDL 100,907. Models with one-and two-tissue compartments were used to analyze these T ACs. The two T compartments for the preblocking study presumably reflect free and nonspecific binding. Nonlinear fitting was performed to estimate the kinetic parameters K I (mLimin/mL), k2' ks, and k6 (min-I ) for the 2T compartment model (Fig. I) , and the total volume of distribution V (mLlmL) was calculated as (Kllk2)(1 + kslk6)' For the I T compartment model, the influx and efflux rate constants, Kj and k;, were estimated.
Control study analysis. Because two T compartments were necessary to describe the preblocking data, to include specific binding, a model with three ti ssue compartments (3T) was used for the control studies (see Fig. 1 ). The three T compartments have six rate constants, with k3 and k4 representing the rates of association and dissociation from the receptor, respectively. However, it is not possible to estimate simultaneously the six parameters from control T ACs. Therefore, to apply the 3T model, the data of the preblocking studies were first analyzed with a 2T model. Using the whole-brain curve of the preblock ing study, four parameters (K I , k2, ks, and k6) were estimated.
To improve the stability of subsequent fits, the ratio kslk6 from the whole-brain fit was fixed for all regions under the assump tion that the fraction of nonspecifically bound tracer was con stant throughout the brain. Three parameters, K I , Ve (K/k2), and ks, were then estimated for all regions in the preblocking Cp' radioactivity concentration in plasma; Ct, tissue free ligand;
Cb, specifically bound tracer; Cns' nonspecifically binding ligand.
The portion of the model to the left of the dashed line was used for analysis of the preblocking studies. study with fixed kslk6' Next, using data from the control study, K I , k3, and k4 were estimated for all regions with fixed regional values of Ve, ks, and k6. V was calculated as VeCl + k31k4 + kslk6), and the binding potential (BP) was calculated as k J lk4.
In all cases. a correction for the time delay f),.t between the plasma input curve and the brain was performed using the whole-brain TAC. A IT model including f),.t was applied to these data for 0 to 30 minutes. This estimated f),.t value was used for all regions. In performing least -squares fitting, the data were weighted according to the noise-equivalent counts (NEC) (Strother ct aI., 1990) for each frame, and the model accounted for the averaging of counts over each frame duration. To elimi nate the contribution from intravascular radioactivity, the first two frames (I minute of data) were discarded during the fitting process.
Preblocking occupancy simulation. Based on the preblock ing data, we proposed the 3T model for the control C I C]MDL 100,907 data. This approach is appropriate if the 5-HT2A re ceptors were completely occupied by the cold MDL 100,907. If receptor blockade was not complete, it might be incorrect to assume that a 2T model is necessary to describe free and non specific binding. To verify that the specific binding sites were in fact completely blocked for the entire study. a simulation was performed. From the input functions of the control studies scaled by injected dose (n = 12), an input function (nmol/gl min) for cold MDL 100,907 was generated for a bolus injection of 400 nmol/kg (assuming a mean body weight of 8.7 kg).
From this input function, Cb, the concentration of bound MDL 100,907 was computed based on the 3T model (see Fig. I ) and the following differential equations:
e I C]MDL 100,907 parameter values for frontal cortex were used in the simulation. Bmax values of 13, 33, and 83 pmol/g for human frontal cortex (Laruelle et aI. , 1993) , rat prefrontal cor tex (Leysen et aI., 1982) , and monkey insular cortex (Lopez Gimenez et aI. , 1998), respectively, were used. The parameter k on was calculated as kJIBmax. A fourth-order Runge-Kutta al gorithm was used to solve the above differential equations.
Simplified methods
The 3T model requires several parameter values obtained from the preblocking data and is thus not a practical method for routine use. Therefore, we tested the following simplified ap proaches (Koeppe et aI., 1991) to define the best method for [ II C]MDL 100,907:
• 1 T model: Estimated parameters were K I and k;. period automatically for each region, linear least-squares fitting was performed to estimate the slope V using data from to to 120 minutes, where the starting time to was varied. The optimal to was chosen as the one where the linear fit produced the mini mum coefficient of variation-that is, cr v/V, where cr v is the standard error of V. In comparing the simplified methods, V values were computed and compared with the 3T V values.
Simulation of simplified methods. To evaluate the simplified methods, computer simulations were performed by simulating TACs with the 3T model. A standard metabolite-corrected in put function was obtained from the control studies (n = 12). TACs of frontal cortex (high binding region), basal ganglia (medium binding region), and cerebellum (low binding region) were computed using the standard input function and averaged kinetic parameters of K) to k6 from the 3T control fits. The statistical noise at time t (cr(t» was estimated from the mean NEC and the mean pixel count (n p ix) in each ROI from the following relation (Watabe et aI., 2000) :
where C(t) is the ROI curve and the factor 621 produced a noise level that matched that found in the monkey T ACs. The statis tical quality of these monkey data is better than that obtainable in humans because of the smaller size of the monkey and the large injected dose. Therefore, the NEC profile was also scaled to simulate a higher noise level by reducing the injected radio activity by a factor of 10. V values for each TAC were esti mated using the 3T, 2T', and Logan graphical method, and the values were compared. For the Logan analysis, the automated method for choosing the fitting time interval was used.
RESULTS
Input function
The parent compound was rapidly metabolized, with unmetabolized fractions of 67% ± 10%, 20% ± 5%, and 11 % ± 3% at 5, 30, and 60 minutes, respectively. Pe ripheral metabolism was faster than that reported for hu mans by Ito et al. (1998) (40% un metabolized at 50 minutes), similar to other tracers. Figure 2 shows an example of the unmetabolized fraction of C l ClMDL 100,907 with the fitted curve from Eq. l. The parameters ex and [3 in Eq. 1 were estimated as 00408 ± 0.023 and 0.262 ± 0.075 (n = 16), respectively. The plasma free fraction was 34.0% ± 3.7% (n = 16).
PET studies
Preblocking studies. After 400 nmol/kg MDL 100,907 was administered, there was a minor drop in heart rate and blood pressure; these parameters returned to baseline within approximately 20 minutes. Figure 3 shows an ex ample of T ACs for frontal cortex and cerebellum with fitted curves for the preblocking study. The cold dose of MDL 100,907 blocked specific binding, as can be seen by comparing the preblocking data with the control TACs (Fig. 4) . For all regions, the IT model was not sufficient to describe the TACs (see Fig. 3 ). The F sta tistic showed that the 2T model produced a statistically better fit than the IT model in all cases (P < 0.001). Regional parameters K1, Ve, and ks from the preblock ing study with fixed kslk6 are shown in Table 1 . The ratio kslk6 used in each fit was determined from a fit of the whole-brain TAC of that monkey, The group kslk6 values were l. l0 ± 0.20 (n = 4). Kl values were high, with large interanimal standard deviations, There was also substantial variability in ks, even with a fixed value for the kslk6 ratio, V ranged from 20 to 28 mLlmL, with much smaller interanimal variability. There were no re gional differences in the parameters K" ks, or V, but a significant regional variation was detected in Ve (P < 0.001, analysis of variance).
Control studies and the 3T model. By using regional mean Ve and ks values and the global kslk6 ratio from the four preblocking studies, the 12 control studies were ana lyzed with the 3T model. Figure 4 shows one example of TACs from frontal cortex and cerebellum with the fitted curves. Table 2 shows the estimated parameters from the 3T model (n = 12). The highest values for the total volume of distribution (V) were observed in frontal cor tex, with intermediate values in basal ganglia and the lowest values in cerebellum. In all regions including the cerebellum, the control V values were significantly greater than the preblocking values (one-tailed t-test, P < 0.01), which suggests the presence of specific binding in the cerebellum. As expected, binding potential (BP) val ues had a similar pattern to the V values, but with a larger percentage variability because the average nonspecific binding level determined from the preblocking studies was subtracted. This regional pattern with a rank order of frontal cortex> basal ganglia> cerebellum agrees with the in vitro distribution of the receptors in rat and human brain (Pazos et aI., 1985 (Pazos et aI., , 1987 .
The volume of distribution V is expected to be linearly proportional to the plasma free fraction,j p (Carson et aI., 1998) . When V values were normalized by f p (i.e., V(f p ) , the percentage standard deviation of all regional values was reduced by approximately 20%.
As shown in Tables I and 2 , K, values were large in all regions, which indicates that extraction is high and that tracer delivery is limited by blood flow. There was also a strong correlation between K, values of [ 'I C]MDL 100,907 and CBF values measured with [ , s O]water (K, = 1.35 CBF -0.08, r = 0.93, n = 96, 12 control studies x 8 ROIs). The scale factor of 1.35 may reflect methodologic differences in input function measurement and time delay correction.
In the fitting procedure, the time delay, !1t, between the arterial input function and the brain T ACs was in cluded. If the time delay correction was not applied, the fit quality was significantly worse, as measured by the Akaike Information Criterion (Akaike, 1976) (paired t test, P < 0.001). As shown in Tables 1 and 2, [ " C]MDL 100,907 has high K, values, and thus the correction for time delay is important.
Test-retest reliability. Three animals were scanned twice in the same day under control conditions. V values in all regions decreased in the second scan from 3% to 24% in two of the three animals. In one animal, the V values in all regions increased from 20% to 40%. The regions with high specific binding such as frontal cortex had larger percentage changes in V than regions with low specific binding, such as the cerebellum. Changes in K, between successive scans were also variable but showed no consistent pattern. Part of the variability in V values is caused by uncertainty in the measurement of the input function. This effect is reduced by calculating the ratio of regional V values to that in cerebellum, in which case the test-retest reliability was improved. For example, for frontal cortex, the mean absolute test-retest percentage differences in V and the V ratio were 27% and 17%, The rati o ksfk6 was fi rst determin ed for each mon key by fi ttin g the whole brain TA C. Mean kslk6 values were 1.10 ± 0.2. Three ad di ti on al parameters, K I (m Llmin . mL l, Ve( mLl mL ), and ks (m in-I) , were estimated and V (m Ll mL) was calc ulated from Ve(l + kslk6)' Ki netic parameters of K, (mUm in· mL), k3 (m in -') , and k4 (m in-') were estim ated . Bind in g potential (BP = kik4) an d total distribution volume V (Ve(1 + k,lk4 + kslk6), mUmL) were calc ulated from the estim ated parameters.
respectively. Another possible explanation for the vari ability is the mass of injected MDL lOO,907. In all three cases, the scan with the lower injected mass had the higher V values, suggesting that the injected mass in the control studies had an effect on the specific binding.
Pre blocking occupancy simulation. To assess the com pleteness of receptor blockade in the preblocking study, a simulation was performed. For the simulated Bm ax val ues of 13 and 33 pmol/g, more than 99% of the binding sites were occupied 1.5 to 2.0 minutes after injection of cold MDL lOO,907. At 120 minutes, the occupancy re mained at greater than 97%. For a Bm a x value of 83 pmol/g, the occupancy peaked at 99% at 7 minutes (2 minutes after tracer injection), with occupancy decreas ing to 92% by 120 minutes. These simulation results support the assumption that the preblocking data repre sent only free and nonspecifically bound tracer in the brain.
Simpler methods
To develop a fitting procedure appropriate for human data, where preblocking values are not available, the IT, 2T, and 2T' models were tested. As shown in Fig. 5 , the 1 T model (dashed line) could be used to represent T ACs for receptor-rich regions such as the frontal cortex. It was not, however, a suitable model to represent the T ACs in receptor-poor regions such as the cerebellum. In these regions, the 2T model produced adequate fits. However, in high V areas such as the frontal and occipital cortex, the 2T model did not reach convergence or obtained values of k3 and k4 with large standard errors. For ex ample, of the fits that did converge, the mean percentage standard error of k3 for the frontal cortex was 21 % for the 2T model versus 8% for the 2T' model. It appears that the combination of kinetic parameters for this tracer pro duces unreliable estimates of the parameters of the 2T model in regions with high specific binding. Table 3 shows the estimated kinetic parameters from the 2T ' model for the control studies. This model was able to fit T ACs from all regions quite well. In the 2T' model, k3 and k4 were estimated with standard errors of 5% to lO%. KJ values estimated by the 2T' model and 3T model were strongly correlated, with the 2T' values J Cereb Blood Flow Metab, Vol. 20, No.6, 2000 being slightly smaller than the 3T values (KJ (2T') = 0.930 KJ (3T) + 0.0278, r = 0.995). The k3 and k4 values from the two models were less strongly correlated (r = 0.827 and 0.825, respectively), as were the BP values (r = 0.794). However, the V values were highly correlated (V (2T') = l.00 V(3T) -4.58, r = 0.973).
The 3T model produced less variance in mean k4 val ues across regions than the 2T' model (see Tables 2 and  3) , i.e., 29% coefficient of variation for 3T and 40% for 2T'. If k4 is the receptor dissociation rate and the ligand binds to a single receptor, there should be a small vari ance in k4 across regions. This reduction in interregional variation in k4 therefore suggests that the 3T model may in fact be more physiologically appropriate than the 2T' model. Table 4 shows Kin etic param eters of K, (mL/min· mL) , k3 (min-') , an d k4 (min-') were estim ated. Total di stributio n volume V (Ve(l + k31k4 + kslk6l, mL/mLl was ca lc ulated from the estim ate d parame ters. For each an im al, Vo (K/k2) was estim ate d fro m a 2T mo de l fi t of the cerebeliu m an d appli ed to all regi on s. Mean Ve values were 11.3 ± 2.8 mL/mL. fitting that were chosen by the automatic algorithm were 32 ± 25, 30 ± 9, and 59 ± 9 minutes for frontal cortex, basal ganglia, and cerebellum, respectively. This vari ability in to between regions is not unexpected, given that the Logan method was derived from the I T model, i.e., if the data are consistent with a I T model, the Logan curve should be linear from to = O. The large to value for cerebellum indicates the cerebellum curve consists of multiple compartments, consistent with the poor fit to the IT model (see Fig. 5 ). The to value for frontal cortex was lower than that in the cerebellum, consistent with its behavior as close to the 1 T model. There was large vari ability in the to values for frontal cortex, but this did not have a major effect on the V values. If to was fixed to the mean value of 32 minutes for frontal cortex, the resulting V value was 57.9 ± 18.0 mLlmL, compared with the original value of 58.5 ± 19.5 mLimL.
Simulation of simplified methods. Table 5 shows the results of the simulation of the 3T model with estimation of V by three methods with different noise levels. Logan analysis and the 2T ' model underestimated V compared with the 3T model, similar to the results observed in the actual PET data (see Table 4 ). However, there were sev eral differences between the simulation and the observed data (see Tables 4 and 5 ). For example, the statistical uncertainty of the 2T ' estimate was somewhat smaller than with the Logan method in Table 4 , but the reverse was true for the simulation. The absolute variability level in the simulation was much lower than the real data because the simulation used averaged kinetic parameters. With the higher noise level, the 3T and 2T ' data did not demonstrate any change in V estimates, and the variabil ity increased in the expected manner. However, in the higher-noise case, the Logan values became more biased and the variability did not increase as much as expected. This effect was partly caused by the automatic method for choosing to, although increased bias in the Logan estimates persisted even with fixed to in the higher-noise case. Bias in Logan slopes has been previously demon strated (Carson, 1993; Slifstein and Laruelle, 1999) and is produced in part by violating the assumptions of the linear least-squares fit, i.e., the independent variables are not noise-free and the noise in each data value is not independent.
DISCUSSION
In this study, we examined several models for analysis of e ' C]MDL 100,907 PET data. Based on the preblock ing data, a model with two tissue compartments is nec essary to describe free and nonspecifically bound tracer. Therefore, we used the 3T model for the control studies where specific binding was present. Although the 3T model may be the most physiologically appropriate model to describe the kinetics of [ " C]MDL 100,907, the method is not practical for application to routine human studies because of the need for preblocking data. For in regi on s. 
Serotonin tracers
Several radiotracers have been used to assess 5-HT 2 A receptors, with the quantification method varying by li gand. Biver et aI. (1994) analyzed e S Flaltanserin human data using a 3T model. First, K" k20 ks, and k6 were estimated in the cerebellum, and parameters of other re gions were estimated with fixed values of k2' ks, and k6.
Human e S Flaitanserin data were also analyzed by Logan graphical analysis (Sadzot et aI., 1995) applied to preb locking and control studies. Assuming that there was only nonspecific binding in the cerebellum, BP was com puted from the Logan slopes of the receptor-rich region and the cerebellum. However, in the preblocking study, the Logan plot was not linear for the cerebellum before 15 minutes after injection, indicating that a 2T model was necessary for the cerebellum, similar to our results.
Interpretation of e s Flaltanserin data, however, is af fected by the presence of radio labeled metabolites in the brain (Lopresti et aI., 1998; Tan et aI., 1999) .
[ 1 2 3 I1R93274 is a highly selective 5-HT2 A receptor ligand for single photon emission computed tomography. Baboon data were analyzed with a 2T model (Abi Dargham et aI., 1997) , and it was again found that this model provided a significantly better fit for the cerebel lum than the 1 T model. Other ligands for the serotonin 5-HT2 A receptor include e S Flsetoperone (Blin et aI., 1988 (Blin et aI., , 1990 Kapur et aI., 1997) and [ 11 C]NMSP (Wong et aI., 1984) , although both of these tracers have signifi cant affinity for the D2 receptor as well.
Model compartments and nonspecific binding
With both the 3T and 2T' models, reliable fits of con trol data could be obtained only if no more than three parameters were allowed to vary. The four parameters of J Cereb Blood Flow Me/ab, Vol. 20, No.6, 2000 the 2T model could not be reliably estimated in control studies, particularly in the regions with highest receptor binding because of numerical identifiability problems. This effect has been found with several receptor-binding ligands and is caused by the combination of kinetic pa rameter values, i.e., one of the two exponentials in the model equations is the dominant term. The impulse re sponse fraction (Carson et aI., 1998) can be used to pre dict the reliability of kinetic parameter estimation for the 2T model:
where A I ' a I , A2, and a2 are the coefficients of the two exponentials in the solution to the 2T model (a, < (2) and t is the duration of the experiment. The smaller the value of Eq. 4, the greater the difficulty in determining the parameters of the 2T model. Using the kinetic pa rameters in Table 3 , the impulse response fraction values for the frontal cortex and cerebellum were 1.2% and 28%, respectively. It is thus more difficult to distinguish two compartments in T ACs of the frontal cortex.
Thus, successful modeling of a TAC by a IT model is by no means demonstration of the lack of specific bind ing. Further, the need for two compartments to describe a T AC is not proof of specific binding, as demonstrated by our preblocking data. This interpretation differs from that of Ito et aI. (1998) , who suggested that there was specific binding in the cerebellum based on the need for a 2T model. We interpreted the two compartments in the preblocking data as corresponding to free and nonspe cifically bound tracer. However, we have no validation data to show that the preblocking fit succeeded in accu rately separating the total binding into those two com ponents. If this separation is incorrect (i.e., Ve is inaccu rate), then the estimates of k3 and BP will be affected. It is also possible that the second tissue compartment cor responds to low-affinity binding to a high-density recep tor distributed uniformly in the gray matter. Other factors such as tissue heterogeneity may contribute to the need for a 2T model in a region with no specific binding.
In performing the analysis, the early data points were excluded so that intravascular radioactivity could be ig nored in the model. This approach is appropriate only if tissue radioactivity concentrations are high in compari son to whole blood activity (including metabolites). This is the case for [ ll C]MDL 100,907. In the preblocking studies, V, the equilibrium ratio of tissue to metabolite corrected plasma, was approximately 20 mLimL. At late times, the parent compound represents approximately 10% of plasma radioactivity, so assuming a blood vol ume of approximately 4% (0.04 mL/mL) , intravascular radioactivity can contribute no more than 0.4 mL/mL to KINETIC ANALYSIS OF [ II CJMDL 100,907 907 the measured V values (i.e., -2%). This component will be smaller in the control studies.
Comparison with human results
The estimated parameters K I and k2 from the 3T model were similar to the parameters obtained in humans (Ito et aI., 1998) with the 2T ' model. The range of k3 and k4 values was also similar in the human data (k3: 0.03 -0.33 min-I ; k4: 0.01 -0.06 min-I ) compared with the monkey data (k3: 0.01-0.33 min-I ; k4: 0.02 -0.08 min-I ). V values obtained in the control data were 40% to 60% smaller in cortical regions than those obtained in human data (Ito et aI., 1998) ; however, the mean V val ues in cerebellum were similar (human 31, monkey 28 mLlmL). Possible contributing factors to the differences between human and monkey include species differences, specific activity, and the partial volume effect. In addi tion, anesthesia may also affect receptor binding by al tering the environment of the membranes in which the receptors reside (Kobayashi et aI., 1995) .
Specific binding in the cerebellum
By comparing the results of the preblocking and con trol studies, we found that there was specific binding in the cerebellum, consistent with in vitro findings (Pazos et aI., 1985 (Pazos et aI., , 1987 . In this study, ROTs were placed directly on the PET images, and errors in ROI placement could produce biases in the T ACs, particularly in the cerebel lum, which had the lowest uptake. To verify that the specific binding in the cerebellum was not an artifact of ROI placement, we used magnetic resonance (MR) im ages (coronal images of 192 x 192 x 80 pixels; pixel size 0.4 x 0.4 x 1 mm) to verify region placement. MR-to PET registration was carried out by the method of Woods et al. (1993) using PET images summed from 0 to 60 minutes after injection. This analysis was applied to control and preblocking studies in three animals. There was a change of only 2% ± 5% in the cerebellum V values (using the 3T model for the control studies and 2T model for the preblocking studies) between manually drawn and MR-registered ROIs. Thus, the specific bind ing of the cerebellum was not an artifact of ROI place ment.
Use of a reference region for receptor analysis (Lam mertsma and Hume, 1996) is highly desirable because it avoids the complexity of arterial sampling and metabo lite determination. Such a method is valid if the reference region has little or no specific binding and if the results agree with estimates obtained using the arterial input function. In many cases, the cerebellum has been used as a reference region. Because we found specific binding in the cerebellum, it appears that this region is not suitable for use in a reference region analysis. A second limita tion on the use of the cerebellum as a reference region is that the conventional analysis assumes that the T AC of the reference region can be well described by a I T model (Lammert sma and Hume, 1996) . Mathematically, it is possible to develop a reference tissue model in which there are two compartments in the reference region, al though it is more difficult to determine the kinetic pa rameters than in the conventional method because of the additional parameters.
Receptor occupancy by injected MDL 100, 907 We used a large dose of radioactivity, motivated by the need for good statistical counts to measure plasma metabolites. Therefore, we were concerned that even with high specific activity, some receptor occupancy by the injected MDL 100,907 was possible in the control studies, particularly in light of the test-retest results. To assess occupancy in control studies, we used a human frontal cortex B m ax value of 164 ± 14 fmol/mg protein (Laruelle et aI., 1993) , a value lower than that reported for monkey and rat. If 80 mg protein corresponds to 1 g brain tissue (Snyder et aI., 1984) , B m ax is 13.1 pmol/g. If the bound concentration is approximately 400 nCi/ccl mCi injected (see Fig. 4 ) for a 30-mCi injection and specific activity is 1,000 mCillLmol, then the bound con centration is approximately 12 pmol/cc. This comparison suggests that we must consider the effect of injected mass on calculated V. If the injected mass did produce detectable receptor occupancy, we would expect to find a significant correlation between mass/kg and V or BP values. We did find a negative correlation between V and injected mass (r = -0.448), but it did not reach statis tical significance (P = 0.07, one-tailed).
To test the potential mass effect directly, we per formed PET scans in one animal with a large difference in injected mass (0.23 and 3 nmol/kg) at the same radio activity dose. We analyzed the two scans by the 3T model and obtained V values for frontal cortex of 84.1 and 75.8 mLlmL and for cerebellum of 33.8 and 35.8 mLlmL in the first and second scans, respectively. Therefore, this single experiment suggested only a mod erate effect of injected mass on the control data.
To examine the discrepancy between the predicted oc cupancy and that found in this paired study, a simulation was performed in a similar manner to that used for the preblocking study. TACs for the frontal cortex were gen erated with 0.25 and 2.5 nmol/kg injected MDL 100,907 using a standard input function and mean kinetic param eters and varying the value of B m ax . To match the result of approximately 10% reduction in V value (84.1 to 75.8 mLlmL) between the two experiments, a B m ax value of 50 pmol/g was required. This value is within the range of values reported in monkey (Lopez-Gimenez et aI., 1998) . We conclude that occupancy by unlabeled MDL 100,907 in the control studies had a modest effect on our resulrs.
Choice of simplified method
Although the 3T model is presumably the most physi ologically appropriate model, this approach is not practical for routine use because it requires knowledge of parameters from a preblocking study. The 2T ' model seems to be the best compartmental method among the simplified methods. However, the method's assumptions are not ideal. In the 2T ' method, the Ve value from the 2T fit of the cerebellum was applied to all regions. This approach might be physiologically appropriate if Ve rep resented the total pool of free plus nonspecific ally bound tracer; however, Ve from the 2T model (11.3 mLlmL) significantly underestimated V from the preblocking studies (20 to 28 mLlmL).
Alternatively, use of the Logan graphical method is awkward for rllC]MDL 100,907 because the timing for beginning the linear fit (to) is variable between subjects and regions. It is possible simply to use a fixed time for all regions. The Logan graph did not become linear until approximately 60 minutes in the cerebellum, however; thus only a small fraction of the statistical counts would be used because of the short half-life of lIe. The simu lation indicated that the Logan graphical method can produce biased parameters, particularly when the noise level in the data was increased, consistent with previous simulations (Carson, 1993; Slifstein and Laruelle, 1999) . Therefore, we conclude that the Logan method, with its ease of implementation, is useful only when there are sufficient statistics in the data. For higher-noise cases the 2T ' model is the best choice for analysis of C lC]MDL 100,907 studies.
